SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
  
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Parra Raul Jr.
(Last) (First) (Middle)
1600 WEST MERIT PARKWAY
(Street)
SOUTH JORDAN UT 84095
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
MERIT MEDICAL SYSTEMS INC [ MMSI ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
CFO AND TREASURER
3. Date of Earliest Transaction (Month/Day/Year)
11/05/2024
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, No Par Value 2,770 I By 401(k) Plan(1)
Common Stock, No Par Value 11/05/2024 M 4,000 A $44.8 16,007 D
Common Stock, No Par Value 11/05/2024 M 30,000 A $55.73 46,007 D
Common Stock, No Par Value 11/05/2024 S 29,646 D $98.02 16,361(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-qualified stock options (right to buy) $44.8 11/05/2024 M 4,000 03/02/2019(3) 03/02/2025 Common Stock 4,000 $0 0 D
Non-qualified stock options (right to buy) $55.73 11/05/2024 M 30,000 03/01/2020(4) 03/01/2026 Common Stock 30,000 $0 0 D
Non-qualified stock options (right to buy) $37.71 02/26/2021(5) 02/26/2027 Common Stock 10,722 10,722 D
Non-qualified stock options (right to buy) $56.25 03/19/2022(6) 03/19/2028 Common Stock 9,681 9,681 D
Non-qualified stock options (right to buy) $65.03 02/28/2023(7) 02/28/2029 Common Stock 14,570 14,570 D
Non-qualified stock options (right to buy) $70.58 02/28/2024(8) 02/28/2030 Common Stock 13,576 13,576 D
Explanation of Responses:
1. Represents plan holdings as of 11/05/2024.
2. The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.000 to $98.026, inclusive. The reporting person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
3. Becomes exercisable in equal annual installments of 20% commencing 03/02/2019.
4. Becomes exercisable in equal annual installments of 20% commencing 03/01/2020.
5. Becomes exercisable in equal annual installments of 25% commencing 02/26/2021.
6. Becomes exercisable in equal annual installments of 25% commencing on 03/19/2022.
7. Becomes exercisable in equal annual installments of 25% commencing on 02/28/2023.
8. Becomes exercisable in equal annual installments of 25% commencing on 02/28/2024.
/s/ Brian G. Lloyd, Attorney-in-Fact 11/07/2024
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Merit Medical Systems (NASDAQ:MMSI)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024 Plus de graphiques de la Bourse Merit Medical Systems
Merit Medical Systems (NASDAQ:MMSI)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024 Plus de graphiques de la Bourse Merit Medical Systems